Adamis Pharmaceuticals Corp - 92130 San Diego, CA

Business Name: Adamis Pharmaceuticals Corp
Categorized In:
Address: 11455 El Camino Real # 310, San Diego, CA 92130
Phone Number: (858) 997-2400
Contact Person: Dennis Carlo, Chief Executive Officer
Website Address: adamispharmaceuticals.com
NAICS Code: 4461100
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 1989
Employee #: 1 to 4
Location Type: Headquarters
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Sunovion Pharmaceuticals Inc - San Diego, CA 92130
Zogenix Inc - San Diego, CA 92130
Centagen - San Diego, CA 92130
Soledad Pharmaceuticals - San Diego, CA 92130
Surefire Diagnostics - San Diego, CA 92130
Mei Pharma Inc - San Diego, CA 92130
Sunovion Respiratory Development Inc - San Diego, CA 92130
Stratum Medical Corp - San Diego, CA 92130
Kuki Atsuo - San Diego, CA 92130
Elcelyx Therapeutics Inc - San Diego, CA 92130
Calixa Therapeutics Inc - San Diego, CA 92130
Ingenome Inc - San Diego, CA 92130
Ader Enterprises Inc - San Diego, CA 92130
Ocera Therapeutics Inc - San Diego, CA 92130
Remora Pharmaceuticals Inc - San Diego, CA 92130
Brighton Pharmaceuticals Inc - San Diego, CA 92130
Sequel Pharmaceuticals Inc - San Diego, CA 92130
Oprx Pharmaceuticals Inc - San Diego, CA 92130
Sequel Pharmaceuticals - San Diego, CA 92130
Nerveda Inc - San Diego, CA 92130

Adamis Pharmaceuticals Corp provides professional from its headquarters at the coordinates 32.926052,-117.23722.

The company offers BOTH variables under the SIC code 2834 and NAICS code 4461100, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 1989, the company can now be visited at 11455 El Camino Real # 310, San Diego, California 92130 or contacted through representative Dennis Carlo, Chief Executive Officer at (858) 997-2400.

For frequently asked questions and further inquiries about professional , get to know more about Adamis Pharmaceuticals Corp through its company website at adamispharmaceuticals.com. Engage with this business on its social media platforms through on Twitter and on Facebook.